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Prednisolone can increase glomerular permeability to proteins
in nephrotic syndrome
JACK F.M. WETZELS, HENK E. SLUITER, ANDRIES J. H0ITsMA, PIET J.J. VAN MUNSTER,
and ROBERT A.P. KOENE
Department of Medicine. Division of Nephrology and Laboratory of Pediatrics, University Hospital, Nijmegen, The Netherlands
Prednisolone can increase glomerular permeability to proteins in
patients with a nephrotic syndrome. In patients with a nephrotic syn-
drome administration of prednisolone causes an increase of proteinuria.
To elucidate the mechanism of this effect we have studied the acute
proteinuric effect of prednisolone. 125 to 150mg intravenously, in nine
patients (7 M, 2 F) with a nephrotic syndrome. Mean age (± SD) of the
patients was 53 6 years, mean endogenous creatinine clearance 104
30 mI/mm, and mean proteinuria 7.7 3.0 g/24 hr. After administration
of prednisolone, urinary total protein excretion rose in all patients from
a mean (±sFM) of 4.89 0.59 mg/mm before to 9.09 0.99 mg/mm at
five hours after administration (P < 0.01). Glomerular filtration rate
(inulin clearance), effective renal plasma flow (PAH clearance), and
filtration fraction did not change significantly. The increases of urinary
excretion of albumin (median %: +92%), IgG (median %: +88%), and
transferrin (median %: +76%) were comparable and correlated signifi-
cantly. Urinary excretion of /32-microglobulin did nol change signifi-
cantly however. We conclude that intravenous administration of
prednisolone to patients with a nephrotic syndrome causes an increase
in urinary protein excretion rate which cannot be explained by changes
in renal hemodynamics or tubular protein reabsorption, and which
therefore must be the result of a change in glomerular permselectivity
characteristics.
Glucocorticoid treatment is regularly used in patients with a
nephrotic syndrome due to minimal change disease or membra-
nous nephropathy [1, 21. In order to reduce side effects of
corticosteroid therapy an alternate day regimen has been ad-
vised [2]. While treating patients with a nephrotic syndrome
according to the above-mentioned Coggin's scheme [21, we
observed a typical fluctuating pattern of proteinuria, due to an
increased proteinuria on prednisone days and a decrease on
non-prednisone days [3, 41. The increase of proteinuria seemed
most prominent on the first day of prednisone treatment [4].
Similar observations of a corticosteroid-induced increase of
proteinuria have been made before in human [5, 6] as well as in
animal studies [7, 8]. The mechanism of this effect is as yet
unclear. Therefore, we have studied the acute effects of
prednisolone on protein excretion rate in patients with a ne.
phrotic syndrome, and concurrently measured changes in renal
hemodynamics and tubular protein reabsorption. Our study
demonstrates that prednisolone acutely increases proteinuria
Received for publication March II, 1987
and in revised form October 1, 1987
© 1988 by the International Society of Nephrology
without causing changes in renal hemodynamics or tubular
protein reabsorption. This suggests that prednisolone increases
proteinuria by causing a change in glomerular permselectivity.
Methods
We studied nine patients with a nephrotic syndrome due to
idiopathic membranous glomerulonephritis (N = 7) or minimal
change disease (N = 2). Mean age (± SD) of the patients was 53
6 years, mean endogenous creatinine clearance (ECC) was
104 30 mI/mm, and mean blood pressure 141/89 14/8 mm
Hg. No patient had evidence of orthostatic hypotension. Fur-
ther clinical data of the patients are presented in Table I.
All patients were studied on the day of the start of
prednisolone therapy. All but two patients were admitted to the
hospital several days before. All patients were on a normal
sodium intake, diet containing 100 to 150 mmol Nat After a
light breakfast patients came to the investigating room at 9.00
a.m., where the experiment took place from 9.00 a.m. till 5.00
p.m. No food was given during the experiment. A firm diuresis
was established by an initial oral water load of 500 to 1000 ml.
Thereafter we tried to maintain urinary flow rate above three
mi/mm by giving water orally or infusing a 5% glucose solution.
To keep urinary pH above 6.0 (which is necessary for correct
measurement of /32-microglobuiin; vide infra) one gram of
sodium bicarbonate was given at regular intervals of 60 to 120
minutes. Glomerular filtration rate (GFR) and effective renal
plasma flow (ERPF) were measured using a continuous infusion
technique. Renal clearances of inulin (InutestR; Laevosan
GMBH, Linz, Austria) and para-aminohippurate (PAH) were
used as markers of GFR and ERPF, respectively. After an
equilibration period of 90 minutes, urine was collected at
regular intervals (45 to 60 mm) for determination of inulin,
PAH, sodium, total protein, albumin, transferrin, IgG, and
132-microglobulin (f32M). In seven patients urine was collected
using a bladder catheter; in two patients it was collected by
spontaneous voiding. After collecting two 45 minute urine
samples for obtaining base-line values, prednisolone-sodium-
succinate was administered intravenously, in a dose of 125 mg
(body weight 75 kg) or 150 mg (body weight > 75 kg). After
administration of prednisolone a total of five urine samples were
collected at intervals of 60 minutes. Before and at the end of
every urine collection period blood for determination of inulin,
PAH, and sodium was sampled via a second indwelling venous
catheter. Furthermore, in seven patients blood samples were
1169
1170 Wetzels ci al: Acute proleinuric effects of prednisolone
Age ECC Proteinuria Other
Patient Sex years Diagnosis mi/mm g/24 hr medication
I M 53 MGN 114 8.3 —
2 M 44 MON 85 6.9 pindolol!
clopainide
3 M 57 MON 86 4.4 atenolol
4 M 56 MGN 113 6.3 —
S M 58 MGN 155 6.9 metoprolol
6 F 49 ML 128 5.8 —
7 M 54 ML 118 12.9 aceno-
coumarol
8 M 55 MGN 85 5.6 —
9 F 50 MGN 51 12.4 metoprolol
Abbreviations are: M, male; F, female; MGN, membranous glomeru-
lonephritis; ML, minimal lesions; ECC, endogenous creatinine clear-
ance (determined from serum creatinine and 24-hr urinary creatinine
excretion).
collected immediately before, and three and five hours after
administration of prednisolone for determination of albumin,
transferrin, lgG and /32M.
Sodium, inulin, and PAH in urine and plasma were measured
using standard semi-automated techniques. Urinary total pro-
tein was measured using the biuret method. Albumin, transfer-
nfl, and IgG in urine and serum were measured by im-
munonephelometry using specific antibodies raised in rabbits.
Serum and urinary /32M were measured using a commercially
available radioimmunoassay (Pharmacia). In one patient no
serum PAH and sodium values could be determined due to
technical difficulties. In another patient urinary /32M was not
measured because of a low urinary pH (pH < 6.0). Filtration
fraction (FF) was defined as GFR/ERPF. The fractional excre-
tion (FE) of a substance was defined as the renal clearance of
that substance divided by the GFR, and expressed as a percent-
age. For statistical analysis Wilcoxon's sign rank test was used.
Linear regression was calculated using Spearman's correlation
coefficient. A P value less than 0.05 was considered significant.
Unless otherwise stated all values are given as means SEM.
The study protocol was approved by the Hospital Ethical
Committee. All patients gave informed consent.
Results
The hydration protocol resulted in a diuresis of more than 3
mI/mm in all but one patient. After administration of
prednisolone urinary flow rate decreased slightly but signifi-
cantly from 5.0 0.6 mI/mm to a lowest mean value of 3.3 0.5
mI/mm (299 38 mi/hr and 197 32 mI/hr. respectively; Fig. I).
Urinary sodium excretion was also significantly reduced (Fig.
1). FENa decreased from 1.96 0.42% toalowest mean of 0.63
0.21% (N = 8; P < 0.02). Serum albumin increased signifi-
cantly from 23.9 1.3 g/liter to 25.9 2.0 g/liter (P < 0.05).
Similar increases were found for IgG and transferrin (IgG: 4.81
0.72 g/liter to 5.13 0.80 g/liter; P <0.05. Transferrin: 1.81
0.22 glliter to 1.98 0.14 g/liter; P < 0.05).
After administration of prednisolone urinary total protein
excretion increased significantly, from a mean value of 4.89
0.59 mg/mm before to 9.09 0.99 mg/mm at five hours after
administration of the drug (293 35 mg/hr and 545 59 mg/hr.
Time, mm
Fig. 1. Effects of prednisolone on urinary flow rate sodiu,n
excretion (UNA V,) and proteinuria. Prednisolone was administrated at
time 0 nsin, Baseline values were obtained from —90 to 0 mm.
0.05, 'P < 0.01 compared to mean baseline values.
urinary protein excretion was already apparent at two hours
after administration of prednisolone. Urinary total protein
excretion increased in all patients, percentual increases (after
five hours) ranging from +21% to + 178% (median +95%).
The renal hemodynamic effects of prednisolone are shown in
Figure 2. Although two patients demonstrated a clear increase
of ERPF at four to five hours after administration of
prednisolone, no significant changes in GFR or ERPF occurred
overall. As a result filtration fraction remained virtually un-
changed during the experiment.
Overall effects of prednisolone on the urinary excretion of the
various proteins measured are given in Table 2, showing
parallel and significant increases of urinary albumin, lgG, and
transferrin excretion, but no significant change in urinary J32M
excretion. The excretion rates for the individual patients of
urinary albumin, IgG, transferrin, and f32M at the start and
during the last hour of the experiment are shown in Figure 3. It
Table 1. Clinical data of the patients UN8\', V,
—90mmoi/hr mi/hr +300
respectively Fig 1). As shown in the figure an increase of is clear from this figure that absolute urinary excretion rates of
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Fig. 2. Acute effects of prednisolone on renal hemodynamics. Abbre-
viations are: GFR, glomerutar filtration rate; ERPF, effective renal
plasma flow; FF, filtration fraction.
albumin, IgG and transferrin rose in all patients. Fractional
excretion of albumin, IgG, and transferrin (which could be
calculated in seven patients) also rose in all patients (albumin
from 0.374 0.098% to 0.578 0.095%, P < 0.05; IgG from
0.066 0.034% to 0.117 0.036%, P <0.05; transferrin from
0.316 0.095% to 0.561 0.110%, P < 0.05). Percentage
increases of urinary albumin, IgG and transferrin excretion
were comparable (albumin: median % + 92%; IgG: median %
+88%; transferrin: median % +76%) and correlated signifi-
cantly (albumin vs. transferrin r = 0.70; P < 0.05; albumin vs.
IgG r = 0.68, P < 0.05; and transferrin vs. IgG r = 0.80; P <
0.01; Fig. 4). From Figure 4 it is apparent that the increase of
urinary IgG excretion exceeded the increase of urinary trans-
ferrin excretion in seven out of nine patients. However, this
difference was not significant (P = 0.08). As a result selectivity
of proteinuria (calculated as clearance IgG/clearance transfer-
rin) did not change significantly. Although overall urinary
excretion of /32M did not change significantly (Table I), an
increase was found in six patients (Fig. 3). The percentual
increase of urinary f37M excretion correlated with the
percentual increase of urinary IgG excretion (r = 0.76; P <
0.05) but was always less. The percentual increase of urinary
132M excretion was less than the percentual increase of albumin
excretion in seven patients (out of eight). Consequently the
ratio of urinary /32M excretion/urinary albumin excretion de-
creased significantly from 0.475 0.304 to 0.308 0.174 (P <
0.05).
Discussion
We recently have confirmed earlier observations in humans
of a corticosteroid-induced increase of proteinuria [3, 4]. To
elucidate the mechanism of this effect we have studied the acute
effects of prednisolone in nine patients with renal disease and
proteinuria.
All patients were on a normal sodium intake when studied.
We noted a slight decrease of urinary flow rate and a firm
decrease of urinary sodium excretion after administration of
prednisolone. Although high doses of prednisolone have been
shown to exert mineralocorticoid effects [9], which could ex-
plain the antinatriuresis that we observed, the decreased uri-
nary flow rate could also be the result of incomplete replace-
ment of urinary losses. This is underscored by the slight
increases of serum albumin, transferrin, and IgG that we noted.
These small increases of serum protein concentrations cannot
explain the observed changes in proteinuria in view of the
marked increases in the fractional excretion of albumin, IgG,
and transferrin. Our study therefore convincingly demonstrates
that prednisolone acutely increases proteinuria in patients with
a nephrotic syndrome. In the rat a glucocorticoid-induced
increase of protein excretion is also found [7, 81. Time relations
differ however, since we noted an increased protein excretion
rate as soon as three hours after administration of prednisolone,
whereas in rats an increased protein excretion rate is not found
before eight hours after administration of the drug.
Several factors could be responsible for the observed rise in
protein excretion rate: alterations in renal hemodynamics,
changes in tubular protein reabsorption, or changes in the
permselective characteristics of the glomerular basement mem-
brane [101. Chronic administration of corticosteroids increases
GFR in animals and man [1 1—151. In man this is most likely the
result of corticosteroid-induced increases of plasma and extra-
cellular volume [131. Observations on the acute renal hemody-
namic effects of corticosteroid administration in man are less
straightforward. Although most authors agree that in human
individuals with normal adrenal function no consistent changes
in GFR or ERPF occur within the first hours after administra-
tion of corticosteroids [16—19], occasionally increases as well as
decreases of both GFR and ERPF have been noted [20, 21]. In
our patients the increases of protein excretion were not accom-
panied by significant changes in GFR and ERPF. Furthermore,
in the few patients who showed an increase of ERPF or GFR at
the end of the experiment these changes were always preceded
by the increases of proteinuria. Taken together this makes a
major role for renal hemodynamics in the proteinuric effect of
prednisolone less likely. However, since in human studies only
information can be obtained on overall renal function, an effect
through redistribution of renal blood flow cannot be completely
excluded.
Corticosteroids interfere with proximal tubular transport of
water and electrolytes, as well as of amino acids [15, 19, 22, 23].
We have used urinary excretion of /3,-microglobulin, an anionic
low molecular weight protein (MW 11.600), as a marker of
tubular protein reabsorption [24, 25]. Under normal circum-
stances up to 99% of the filtered /32M is reabsorbed by the
proximal tubules. Tubular reabsorption of albumin is less
prednisolone
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Table 2. Prednisolone-induced changes in urinary excretion of total protein, albumin, transferrin, IgG. and -microglobulin
—90 to—45 5.18 0.65 4.58 0.53 0.13 0.03
—45 toO 4.60 0.54 4.20 0.46 0.12 0.03
0 to 60 4.40 - 0.48 4.00 0.37 0.11 0.03
60 to 120 5.55 0.51 4.68 - 0.52 0.15 -- 0.04
120 to 180 7.00 r 080h 6.08 063h 0.23 007b
180 to 240 8.21 0.99' 7.36 (1.92k 0.31 0.I2
240 to 300 9.09 O.99' 8.23 - O.8S 0.29 O.O7l
All values are given as mean SEM. Prednisolone was administrated at time — 0 mm. Baseline values were obtained from —90 mm till 0 mm.
a P < 0.05 and h P < 0.01 compared with mean baseline values.
f3,M x 1O
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Fig. 4. Correlation of the increase of urinary iransferrin excretion (
UTr) with the increase of urinary IgG excretion ( UIgG). For
comparison the line of identity is shown.
patients, an increase in the other six patients. Percentual
increase of urinary /32M excretion was always less then the
increase of urinary IgG excretion, and in all but one patient less
then the increase of urinary albumin excretion. This is reflected
by a significant decrease of the ratio urinary /32M excretion/
urinary albumin excretion, which, as indicated above, argues
against a blockade of tubular protein reabsorption. Further-
more, in the case of a defect in tubular protein transport
proteinuria hardly ever exceeds 2 g/24 hr, equalling 1.5 to 2
mg/mm [27]. In most of our patients the increase in protein
excretion rate was considerably greater, which provides further
evidence that the proteinuric effects of prednisolone are not
mediated by a decrease in tubular protein reabsorption.
With the necessary precautions in mind we conclude that the
proteinuric effects of prednisolone cannot be explained by
changes in renal hemodynamics or tubular protein reabsorp-
tion, and thus must result from a change in glomerular permse-
lectivity characteristics. In rat studies the same conclusions
were reached [7, 8]. Although corticosteroids influence GFR in
rats, the increase in proteinuria occurring 8 to 34 hours after
Time, mm
Fig. 3. Acute effects of prednisolone on urinary excretion rates of
albumin, transferrin, lgG, and f32microglobulin (f32M). Values obtained
at the start (0 mm) and in the last hour (300 mm) of the experiment are
shown for the individual patients.
efficient. After blockade of tubular protein reabsorption the
relative increase of urinary f3M excretion exceeds the relative
increase of urinary albumin excretion severalfold [261. This also
explains the increased ratio of urinary f32M/urinary albumin
found in patients with tubular interstitial disease [24]. In our
patients we observed no change in mean urinary /32M excretion.
Individual responses varied, a decrease being found in two
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administration of the drugs was not accompanied by increases
in GFR or lysozyme excretion.
In recent years much has been learned about the permeability
characteristics of the glomerular capillary wall 1281. It has
become evident that the transport of macromolecules through
the glomerular filter is determined not only by molecular size
and configuration (size-selectivity) but also to an important
degree by molecular charge (charge-selectivity). The negatively
charged glomerular basement membrane impairs filtration of
anionic proleins (such as albumin). Selective loss of glomerular
basement membrane charges would result in a preferential loss
of albumin. We have studied the urinary excretion of proteins
with different charge and molecular size such as albumin,
transferrin, and IgG. The increases of urinary excretion of these
proteins were comparable, thus favoring a predominant change
in glomerular size-selectivity.
It is difficult to derive from data reported in the literature how
corticosteroids could change glomerular permselectivity. Since
adrenalectomy impairs the proteinuric effects of renin and
norepinephrine in rats, it is assumed that corticosteroids have a
permissive action on generating this proteinuria [29, 30].
Corticosteroids increase plasma renin activity [31]. In the light
of these observations it is tempting to speculate that changes in
the renin-angiotensin system contribute to the proteinuric ef-
fects that we have observed. Since we did not measure plasma
renin activity or angiotensin II in our patients, we cannot deter-
mine their influence on the proteinuric effect of prednisolone.
However, in view of the homogeneous response in our patient
group it would have been difficult to relate changes in protein-
uria to basal levels of renin or angiotensin II. Furthermore,
angiotensin II increases proteinuria mainly by causing vasocon-
striction of the efferent arteriole, leading to an increased gb-
merular capillary pressure which is reflected in an increased
filtration fraction [291. Recently it was suggested that the pro-
teinuria could be the result of binding of the cationic angiotensin
II to the GBM and the subsequent decrease of GBM negative
charge [30]. The complete absence of changes in FF in our
study and the absence of a predominant increase of albumin
excretion indicate that the nature of the proteinuria after ad-
ministration of prednisobone is quite different, making a contri-
bution of the renin-angiotensin system less likely.
In our study population the response to prednisolone was
quite homogeneous, an increased proteinuria occurring in all
patients. However, we only studied patients with minimal
change disease or membranous glomerulonephritis, and ne-
phrotic range proteinuria. Therefore one should be careful to
apply conclusions drawn from our study to patients with renal
disease and proteinuria from other causes. In fact, from an
ongoing study we have indications that patients with a prolifer-
ative gbomerulonephritis do not respond to corticosteroids in a
similar way. Up to this moment the observed effects do not
seem to have any relation with therapeutic outcome. However,
it is important to realize that during alternate day prednisone
therapy transient changes in proteinuria can occur, which do
not reflect therapeutic failure or success.
In conclusion prednisolone can acutely increase proteinuria
in patients with nephrotic syndrome. The absence of changes in
renal hemodynamics and renal tubular protein reabsorption
suggest that this effect is caused by changes in glomerular
permselectivity. How the changes in glomerular permselec-
tivity are effectuated remains to be determined.
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